Targeting RNA with Small-Molecule Drugs: Therapeutic Promise and Chemical Challenges
- 16 August 2001
- journal article
- review article
- Published by American Chemical Society (ACS) in Accounts of Chemical Research
- Vol. 34 (10) , 836-843
- https://doi.org/10.1021/ar000118k
Abstract
Researchers' increasing awareness of the essential role played by RNA in many biological processes and in the progression of disease makes the discovery of new RNA targets an emerging field in drug discovery. Since most existing pharmacologically active compounds bind proteins, RNA provides nearly untapped opportunities for pharmacological development. The elucidation of the structure of the ribosome and other cellular and viral RNA motifs creates the opportunity for discovering new drug-like compounds that inhibit RNA function. However, further advances in understanding the chemistry and structure of RNA recognition are needed before these promises are fulfilled.Keywords
This publication has 30 references indexed in Scilit:
- The Structural Basis of Ribosome Activity in Peptide Bond SynthesisScience, 2000
- A Detailed View of a Ribosomal Active Site: The Structure of the L11–RNA ComplexCell, 1999
- Probing the Specificity of Aminoglycoside−Ribosomal RNA Interactions with Designed Synthetic AnalogsJournal of the American Chemical Society, 1998
- Direct Observation of Aminoglycoside−RNA Interactions by Surface Plasmon ResonanceJournal of the American Chemical Society, 1997
- Structure of the A Site of Escherichia coli 16 S Ribosomal RNA Complexed with an Aminoglycoside AntibioticScience, 1996
- Structural basis of RNA folding and recognition in an AMP–RNA aptamer complexNature, 1996
- Gene inhibition using antisense oligodeoxynucleotidesNature, 1994
- The Origin of Plagues: Old and NewScience, 1992
- Conformation of the TAR RNA-Arginine Complex by NMR SpectroscopyScience, 1992
- Interaction of antibiotics with functional sites in 16S ribosomal RNANature, 1987